<DOC>
	<DOC>NCT00067262</DOC>
	<brief_summary>The purpose of this study is to determine the safety and effectiveness of Depakote ER (Divalproex Sodium Extended-Release Tablets) compared to placebo in the treatment of bipolar disorder, manic or mixed type in children and adolescents ages 10-17 years.</brief_summary>
	<brief_title>An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>INCLUSION CRITERIA Current primary diagnosis of bipolar I disorder, mania or mixed type Outpatient between 10 and 17 years of age Young Mania Rating Scale score greater than or equal to 20 during screening/washout and at Day 1 EXCLUSION CRITERIA Axis I other than Attention Deficit Hyperactivity Disorder (ADHD), Obsessive Compulsive Disorder (OCD), Oppositional Defiant Disorder (ODD), Conduct Disorder (CD), Panic Disorder; or Axis II (e.g., personality disorder) that would interfere with compliance or confound interpretation of study results Current manic episode is druginduced or secondary to a medical disorder (e.g., antidepressants, hyperthyroidism) Expected to require hospitalization for the current manic episode Participation in psychotherapy that was started within the past 3 months, or if any significant changes are anticipated Has taken atomoxetine or has taken allowed stimulant medication that has not been stable for at least 3 months prior to Day 1, or a dosage adjustment is expected during the study, or that may worsen mood symptoms Unable to swallow tablets Has received depot psychoactive medication within one interinjection interval of Day 1 Urine toxicology screen is positive for phencyclidine (PCP), opiates, cocaine, barbiturates, benzodiazepines or amphetamines History of alcohol or substance dependence within past 3 mos. or substance abuse within past month History of failed treatment on adequate Depakote (DR or ER) for a manic episode within past 12 months Has taken Depakote (DR or ER) regularly for the current manic episode Has serious violent, homicidal, or suicidal ideation</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Bipolar Disorder Type 1 (manic or mixed type)</keyword>
</DOC>